[Clinical evaluations of ofloxacin in the treatment of Mycoplasma pneumoniae pneumonia in adults].
We studied the clinical efficacy of ofloxacin (OFLX) in the treatment of 13 cases of Mycoplasma pneumoniae pneumonia. OFLX was given to each patient orally at 200 mg/dose, 3 doses daily. One case was excluded because of a side effect i.e., nausea. In 12 evaluable cases, the clinical efficacy rate was 100% i.e., excellent in 7, good in 5. OFLX is one of the useful drugs in the treatment of M. pneumoniae pneumonia.
Kikuchi
N
N
Department of Internal Medicine, Chiba Kaihin Municipal Hospital.
Kawashima
T
T
Onozaki
I
I
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D011019:Pneumonia, Mycoplasma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D015242:Ofloxacin